|
Gerald I. Shulman, M.D., Ph.D. is an Investigator of the Howard Hughes Medical Institute and Professor of Medicine and Cellular & Molecular Physiology at Yale University School of Medicine. He is also Program Director of the Yale-General Clinical Research Center, Associate Chief for the Section of Endocrinology/Metabolism, Associate Director of the Yale Diabetes-Endocrinology Research Center, and Associate Director of the Yale Medical Scientist (M.D.-Ph.D.) Training Program. Dr. Shulman completed his undergraduate studies in Biophysics at the University of Michigan, and received both M.D., Ph.D. degrees from Wayne State University. Following internship and residency at Duke University Medical Center, he completed an endocrine fellowship at the Massachusetts General Hospital Harvard Medical School, and did additional postdoctoral work in molecular biophysics and biochemistry at Yale University before joining the faculty at Harvard Medical School. Upon returning to Yale Dr. Shulman's research has focused on the mechanism of insulin resistance in patients with type II diabetes. Over the past 20 years Dr. Shulman has published over 180 articles and has received numerous awards for his scholarly work including the Outstanding Investigator Award of the American Federation for Clinical Research, the Outstanding Scientific Achievement Award (Lilly Lecture) of the American Diabetes Association, and the Diabetes Care Research Award from the Boehringer Mannheim/Juvenile Diabetes Research Foundation. Dr. Shulman has served on multiple scientific review committees including the NIH metabolism study section, the Juvenile Diabetes Foundation Scientific Review Board and the American Diabetes Association Grant Review Panel. Dr. Shulman is a fellow of the American College of Physicians, the International Society of Magnetic Resonance in Medicine and he has been elected to a number of honorary societies including the American Society for Clinical Investigation and the Association of American Physicians.
| 